- Home
- NAMS vs BWLP Comparison
NAMS vs BWLP Comparison
Compare NAMS & BWLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NAMS | BWLP |
|---|---|---|
| Founded | 2019 | 1935 |
| Country | Netherlands | Singapore |
| Employees | 100 | 1444 |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NAMS | BWLP |
|---|---|---|
| Price | $30.89 | $21.70 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $46.75 | N/A |
| AVG Volume (30 Days) | ★ 977.5K | 409.8K |
| Earning Date | 05-06-2026 | 05-19-2026 |
| Dividend Yield | N/A | ★ 7.51% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $17.96 | N/A |
| Revenue Next Year | $540.65 | N/A |
| P/E Ratio | ★ N/A | $15.61 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $21.14 | $11.72 |
| 52 Week High | $42.21 | $22.92 |
Technical Indicators
Market Signals| Indicator | NAMS | BWLP |
|---|---|---|
| Relative Strength Index (RSI) | 40.97 | 64.47 |
| Support Level | $29.23 | $17.45 |
| Resistance Level | $37.29 | $22.58 |
| Average True Range (ATR) | 1.96 | 0.54 |
| MACD | -0.43 | 0.29 |
| Stochastic Oscillator | 7.49 | 97.04 |
Price Performance
Historical ComparisonAbout NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments. The Company has one reportable segment, which comprises the discovery, development, and commercialization of transformative therapies for cardio-metabolic diseases.
About BWLP BW LPG Limited
BW LPG Ltd is an owner and operator of very large gas carriers. It operates in two segments: the Shipping segment, which includes LPG shipping and the Product Services segment, which includes the core shipping business. The Product Services segment derives the majority of the revenue.